Dupixent side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Dupixent. Common side effects include dermatitis atopic among females, and dermatitis atopic among males.

The phase IV clinical study is created by eHealthMe based on 192,254 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 02, 2023

192,254 people who take Dupixent and have side effects are studied.

What is Dupixent?

Dupixent has active ingredients of dupilumab. Currently, eHealthMe is studying from 192,339 Dupixent users.

Number of Dupixent reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Dupixent:

Dupixent (192,339 reports)

Common Dupixent side effects:

Itching: 16,992 reports
Rashes (redness): 14,713 reports
Drug ineffective: 12,259 reports
Dry eyes (lack of adequate tears): 6,010 reports
Dry skin: 4,984 reports
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4,733 reports

All Dupixent side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Levetiracetam and Skin Erosion - now
Armour Thyroid and Leucovorin Calcium drug interaction - 2 seconds ago
Xeljanz Xr and Hip Fracture - 14 seconds ago
Neulasta and Cefotaxime Sodium drug interaction - 14 seconds ago
Lamotrigine and Pneumonia Mycoplasmal - 16 seconds ago
Dilantin and Ultracet drug interaction - 17 seconds ago
Meropenem and Face Oedema - 22 seconds ago
Tri-Sprintec and Fenofibrate drug interaction - 25 seconds ago
Toviaz and Hiatal Hernia - 27 seconds ago
Baclofen and Deafness Unilateral - 28 seconds ago